Observational studyCurrent oncology (Toronto, Ont.)2026

Real-World Outcomes of First-Line Cetuximab and Platinum-Based Chemotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Observational Study and Literature Review.

Zoran Rakušić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.